Contrafect Corp., a 5-year-old biotechnology company in Yonkers, has a new investor from China that plans to make more investments in...
Businesses with employee health and wellness programs are beginning to embrace technology platforms to encourage their employees to improve and monitor...
The banking industry is at a crossroads as interactive ATMs, mobile deposits and other technologies threaten to supplant tellers and branches.
Fairfield County employers say they need more H-1B Visas to hire more highly-skilled immigrants to fill job openings, especially in technology...
Gartner Inc., a Stamford-based information technology and research firm, IBM Corp. has been named the overall marketshare leader in the application...
ZetrOZ L.L.C. was co-founded in 2009 and launched its first portable ultrasound device, UltrOZ, in the spring of 2011 to treat...
Business Journal contributor Brad Scheller recently sat down with Leonora Valvo, CEO of etouches Inc. in Norwalk, for a conversation about...
Priceline.com and United Airlines representatives announced March 21 plans to continue developing their direct-connect technology platform.
Two Fairfield County entrepreneurs were among nine women honored by the Connecticut Technology Council at its annual Women of Innovation awards...
Doris Bucher, associate professor at New York Medical College's Graduate School of Basic Medical Sciences in Valhalla, has led a team...
The National Football League will partner with GE and Under Armour Inc. as part of the four-year, $60 million Head Health...
IBM Corp. announced March 14 the creation of the IBM Customer Experience Lab, dedicated to helping business leaders transform the way...
Tarrytech Computer Consultants separates itself from other Westchester IT companies by being a managed service provider (MSP), marking its 11th year...
Connecticut has reached a $7 million, multi-state settlement with Google Inc. over claims that the search engine giant collected data from...
Contrafect Corp., a Yonkers-based biotechnology company, prepares to begin clinical trials on humans of its first bacteria-killing drug.